معرفی
Gazala Akram is a Senior Teaching Fellow at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, where she contributes to the MPharm and postgraduate programs. She serves as the Course Director for the MSc in Clinical Pharmacy and has a strong interdisciplinary presence in public health and mental health service delivery.
- PhD in Clinical Information Provision for Lay Persons in ADHD, University of Strathclyde (2010)
- Master of Public Health, University of Nottingham (1997)
- Bachelor of Science, University of Strathclyde (1993)
Her research is deeply rooted in her clinical experience, focusing on mental health service delivery, community pharmacy roles, and palliative care. She is particularly interested in expanding the scope of community pharmacists in managing depression and supporting patients with complex psychiatric needs. Her work bridges clinical practice, policy, and education to improve patient outcomes.
The recent article trends highlight a consistent focus on community pharmacy interventions in mental health, including depression services, minor ailments, and opioid harm reduction. Her studies employ qualitative and systematic review methodologies, emphasizing stakeholder engagement and real-world implementation challenges in healthcare systems.
- Fellow of the Royal Pharmaceutical Society (FRPS) (2019, 2024)
- Developing GP and Community Pharmacy Partnerships Award (2014)
- Best Research Poster on Clozapine Metabolic Effects (2014)
- Best Original Research Presentation on ADHD (2010)
Gazala Akram has led and contributed to multiple research projects, including those funded by Pharmacy Research UK and Macmillan. She has supervised students and early-career researchers, though specific names are not listed. Her external roles include serving on the GPhC Fitness to Practice Committee and the Scottish Government’s CSO HIPS Research Committee, reflecting her influence in national pharmacy policy and professional standards.
She is actively involved in research networks and professional communities, including organizing the NORDIC Social Pharmacy Conference 2025 and participating in multi-institutional collaborations focused on mental health and palliative care service innovation.
